Stock A000100 YUHAN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Yuhan Corporation

Equities

A000100

KR7000100008

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
79,600 KRW +1.02% Intraday chart for Yuhan Corporation +4.46% +15.70%
05-16 Yuhan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Korean Sugar Imports Plunge 14% as Diabetes Cases Surge MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Yuhan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Yuhan Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Yuhan Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Yuhan Corporation completed the acquisition of 42% stake in ImmuneOncia Therapeutics Inc. from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q) for $20 million.
CI
Yuhan Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation's Equity Buyback Plan Extended till July 31, 2024.
CI
Yuhan Corporation and J INTS BIO Inks a Licensing Agreement for A New Drug Candidate Targeting HER2 NSCLC
CI
Yuhan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Yuhan Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Yuhan Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A000100 Stock
  4. News Yuhan Corporation
  5. Highlights